Shilpa Medicare Ltd
NSE:SHILPAMED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Shilpa Medicare Ltd
Total Current Liabilities
Shilpa Medicare Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shilpa Medicare Ltd
NSE:SHILPAMED
|
Total Current Liabilities
₹7.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Total Current Liabilities
₹151B
|
CAGR 3-Years
24%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Total Current Liabilities
₹63B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Total Current Liabilities
₹234.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Total Current Liabilities
₹108.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
9%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Total Current Liabilities
₹44.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
Shilpa Medicare Ltd
Glance View
Shilpa Medicare Ltd. engages in the manufacturing of pharmaceutical product and wind power generation. The company is headquartered in Raichur, Karnataka. The firm is engaged in manufacturing active pharmaceutical ingredients (APIs), formulation and development service. The company is focused on new drug delivery systems, peptides/biotech products and specialty chemicals. The Company’s product range include oncology and non-oncology APIs, oncology formulations, biosimilars, ophthalmic, oral dissolving films, biochemical diagnostics, organic intermediates, pilot and production scales and transdermal patches. The company supplies oncology/non-oncology APIs and intermediates. Its oncology APIs products include Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various regulated markets including USA, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-oncology APIs products include Ambroxol (Mucolytic agent) in Europe and Tranexmic Acid and Ursodeoxycholic acid in India.
See Also
What is Shilpa Medicare Ltd's Total Current Liabilities?
Total Current Liabilities
7.8B
INR
Based on the financial report for Dec 31, 2025, Shilpa Medicare Ltd's Total Current Liabilities amounts to 7.8B INR.
What is Shilpa Medicare Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
12%
Over the last year, the Total Current Liabilities growth was 58%. The average annual Total Current Liabilities growth rates for Shilpa Medicare Ltd have been -3% over the past three years , 7% over the past five years , and 12% over the past ten years .
